Skip to main content
. 2021 Sep 8;21:935. doi: 10.1186/s12879-021-06633-3

Table 3.

TB screening algorithm costs among persons with clinical and structural risk factors

First author, Year Country Screening algorithm Source of unit costs Type of unit costs Average cost1 of screening per person Average cost1 of diagnosis per person
Screening Diagnostic tests Staff Equipment Consumables Overhead Transport TB Treatment
Persons with structural risk factors (N = 16)a
 Migrants, refugees, internally displaced persons (IDPs)
  Bogdanova 2019 Russia Mass CXR screening SSM Reported $4 per migrant screened $834 per TB case diagnosed
  Smit 2017 Belgium WHO 4SS, CXR NR Calculated $18 per migrant screened $506,025 per migrant diagnosed with TB
NR $6721 per asylum seeker diagnosed with TB
 Homeless persons and intravenous drug users (IDUs)
  Bogdanova 2019 Russia Mass CXR screening SSM Reported $4-$13 $793 per TB case diagnosed
  Jit 2011 United Kingdom Mobile CXR screening for IDUs and homeless NR Reported NR

$9837 per QALY gained

(UR: $6,302-$27,666)

 Persons who live in urban slums
  Sekandi 2015 Uganda WHO 4SS for all HHC

SSM and

CXR

Reported NR $1371 per additional TB case diagnosed
  Shah 2017 Peru Household visits for WHO 4SS for all HHC Xpert MTB/RIF Reported $32 per person screened $3244 per DALY averted
  James 2017 Cambodia Door-to-door WHO 4SS SSM and Xpert Reported NR $268 per TB case diagnosed
 Members of tribal or indigenous populations
  Sohn 2019 India Household visits for TB education and screening SSM Reported < $1 per person screened $3–5 per TB case diagnosed
 Persons residing in prisons
  Machekera 2019 Zimbabwe WHO 4SS, CXR Xpert MTB/RIF Calculated $14 per person screened $460 per TB case diagnosed
  Smit 2017 Belgium WHO 4SS, CXR NR Calculated $18 per person screened $14,034 per TB case diagnosed
  Winetsky 2012 Former Soviet Union WHO 4SS alone NR Reported $3 per person screened $538 per QALY gained
MMR (CXR) NR Reported $5 per person screened
Xpert MTB/RIF NR Reported $2 per person screened
  Zishiri 2014 South Africa WHO 4SS Xpert MTB/RIF Reported $33 per person screened $1423 TB case diagnosed
 Elderly (55 +)
  Jo 2020 Cambodia (> 55) Symptom screen Xpert, SSM, CXR Reported < $1 per person screened $406 per TB case diagnosed
  James 2017 Cambodia (> 55) Symptom screen Xpert, CXR Calculated < $2 per person screened $340 per TB case diagnosed
  Zhang 2017 China (> 65) Door-to-door symptom screen or CXR CXR, SSM, culture Reported NR $74–$315 per TB case diagnosed
 People living in areas with limited access to healthcare (remote, isolated, hard-to-reach areas)
  Karki 2017 Papua New Guinea Community-wide symptom screening SSM Reported NR $158 per TB case diagnosed
  Jo 2020 Cambodia Symptom screen Xpert, SSM, CXR Reported < $1 per person screened $406 per TB case diagnosed
 Miners (i.e., workers with silica exposure)
  Machekera 2019 Zimbabwe WHO 4SS, CXR Xpert MTB/RIF Calculated $14 per person screened $404 per miner diagnosed
Persons with clinical risk factors (N = 3)b
 Diabetes mellitus
  Bogdonova 2019 Russia CXR SSM Reported NR $21,780 per TB case diagnosed
  Ji 2020 China CXR SSM Calculated  < $2 per person screened $288 per DALY averted
  Machekera 2019 Zimbabwe CXR Xpert Reported NR $2191 per TB case diagnosed
 Respiratory disease
  Bogdonova 2019 Russia CXR SSM Reported NR $32,746 per TB case diagnosed
 Gastro-intestinal, genito-urinary, steroid use or fibrotic chest lesions
  Bogdonova 2019 Russia CXR SSM Reported NR $11,648-$105,754 per TB case diagnosed

aThere is limited evidence on screening among persons with structural risk factors, including migrants (n = 2), homeless persons and IDUs (n = 2), persons who live in urban slums (n = 3), members of tribal or indigenous populations (n = 1), persons residing in prisons (4), elderly (3), people living in remote areas (n = 2) and miners (1). The costs of screening among persons with structural risk factors ranged from $1–33 per person screened and $3–$506,025 per TB case diagnosed. Screening programs were found to be cost-effective in persons living in urban slums and homeless, with reported ICERs of $3244 per DALY averted and $9837 per QALY, respectively. Screening was not shown to be cost-effective in migrants with an of ICER $506,025 per migrant diagnosed. In the Former Soviet Union, screening persons residing in prisons was found to be cost-effective with an ICER of $538 per QALY gained. Door-to-door screening of the elderly in China was shown to be cost-effective with ICERs ranging from US$74 to $315 per additional TB patient diagnosed

bThere is limited evidence on screening among persons with clinical risk factors, primarily from one study in Russia. One study in Russia demonstrated a cost ranging from $11,648 to $105,754 for systematic screening among persons with various clinical risk factors (i.e., gastro-intestinal, respiratory disease, genito-urinary, steroid use and fibrotic chest lesions). Two studies conducted in Russia and Zimbabwe reported the cost per person diagnosed with diabetes mellitus (DM) which ranged from $2191 to $21,780. A cost-effectiveness analysis of patients with DM in China found systematic screening using CXR was cost-effective with an ICER of $288 per DALY averted

ACF active case finding, HHC household contacts, SSM sputum smear microscopy, Xpert GeneXpert, WHO 4SS four symptom screen, mWRDs molecular WHO-approved rapid diagnostics, CXR chest x-ray, NR not reported

1Costs in 2019 USD unless stated otherwise

indicates cost component was explicitly included in unit cost calculation